Free immunoglobulin light chains: A role in minimal change disease

Bioscience Hypotheses

Volumn 2, Issue 3, 2009, Pages 135-142

  Deschênes, Georges ^a,b,c   Doucet, Alain ^c  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

Author keywords

Immunity; Immunosuppression; Nephrotic syndrome; Polyclonal; Variable domain

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; GLUCOCORTICOID; IMMUNOGLOBULIN LIGHT CHAIN; MYCOPHENOLIC ACID; PREDNISONE; RITUXIMAB; TACROLIMUS;

ARTICLE; ATOPY; B CELL LEUKEMIA; B LYMPHOCYTE; CHILD CARE; DNA POLYMORPHISM; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION; HODGKIN DISEASE; HUMAN; HYPOTHESIS; IMMUNOPATHOLOGY; MINIMAL CHANGE GLOMERULONEPHRITIS; NONHUMAN; PROTEIN FUNCTION; PROTEINURIA; RECURRENT DISEASE; REMISSION; THROMBOEMBOLISM;

EID: 67349113883     PISSN: 17562392     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bihy.2009.03.001     Document Type: Article

References (70)

1. Vanhove M., Usherwood Y.K., and Hendershot L.M. Unassembled Ig heavy chains do not cycle from BiP in vivo but require light chains to trigger their release. Immunity 15 (2001) 105-114
2. Aucouturier P., Khamlichi A.A., Touchard G., et al. Brief report: heavy-chain deposition disease. The New England Journal of Medicine 329 (1993) 1389-1393
3. Davis D.P., Khurana R., Meredith S., Stevens F.J., and Argon Y. Mapping the major interaction between binding protein and Ig light chains to sites within the variable domain. Journal of Immunology 163 (1999) 3842-3850
4. Knittler M.R., and Haas I.G. Interaction of BiP with newly synthesized immunoglobulin light chain molecules: cycles of sequential binding and release. The EMBO Journal 11 (1992) 1573-1581
5. Batuman V., and Guan S. Receptor-mediated endocytosis of immunoglobulin light chains by renal proximal tubule cells. The American Journal of Physiology 272 (1997) F521-F530
6. Katzmann J.A., Clark R.J., Abraham R.S., et al. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clinical Chemistry 48 (2002) 1437-1444
7. Redegeld F.A., and Nijkamp F.P. Immunoglobulin free light chains and mast cells: pivotal role in T-cell-mediated immune reactions?. Trends in Immunology 24 (2003) 181-185
8. Wright C.F., Teichmann S.A., Clarke J., and Dobson C.M. The importance of sequence diversity in the aggregation and evolution of proteins. Nature 438 (2005) 878-881
9. Eddy A.A., and Symons J.M. Nephrotic syndrome in childhood. Lancet 362 (2003) 629-639
10. Drummond K.N., Michael A.F., Good R.A., and Vernier R.L. The nephrotic syndrome of childhood: immunologic, clinical, and pathologic correlations. The Journal of Clinical Investigation 45 (1966) 620-630
11. Hoyer J.R., Vernier R.L., Najarian J.S., Raij L., Simmons R.L., and Michael A.F. Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet 2 (1972) 343-348
12. Shalhoub R.J. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 2 (1974) 556-560
13. Mansour H., Cheval L., Elalouf J.M., et al. T-cell transcriptome analysis points up a thymic disorder in idiopathic nephrotic syndrome. Kidney International 67 (2005) 2168-2177
14. Garin E.H., Diaz L.N., Mu W., et al. Urinary CD80 excretion increases in idiopathic minimal-change disease. Journal of the American Society of Nephrology 20 2 (2009 Feb) 260-266 Epub 2008 Dec 3
15. Mathieson P.W. Podocyte-specific gene mutations are coming of age. Journal of the American Society of Nephrology 19 (2008) 190-191
16. Faul C., Donnelly M., Merscher-Gomez S., et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nature Medicine 14 (2008) 931-938
17. Fujinami R.S., Sun X., Howell J.M., Jenkin J.C., and Burns J.B. Modulation of immune system function by measles virus infection: role of soluble factor and direct infection. Journal of Virology 72 (1998) 9421-9427
18. Ravanel K., Castelle C., Defrance T., et al. Measles virus nucleocapsid protein binds to FcgammaRII and inhibits human B cell antibody production. The Journal of Experimental Medicine 186 (1997) 269-278
19. Andreau K., Lemaire C., Souvannavong V., and Adam A. Induction of apoptosis by dexamethasone in the B cell lineage. Immunopharmacology 40 (1998) 67-76
20. Lacki J.K., Mackiewicz S.H., Leszczynski P., and Muller W. The effect of intravenous cyclophosphamide pulse on peripheral blood lymphocytes in lupus erythematosus patients. Rheumatology International 17 (1997) 55-60
21. Chen W., Wang H.G., Srinivasula S.M., Alnemri E.S., and Cooper N.R. B cell apoptosis triggered by antigen receptor ligation proceeds via a novel caspase-dependent pathway. Journal of Immunology 163 (1999) 2483-2491
22. Hao S., Kurosaki T., and August A. Differential regulation of NFAT and SRF by the B cell receptor via a PLCgamma-Ca(2+)-dependent pathway. The EMBO Journal 22 (2003) 4166-4177
23. Bagga A., Hari P., Moudgil A., and Jordan S.C. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome. American Journal of Kidney Disease 42 (2003) 1114-1120
24. Allison A.C., and Eugui E.M. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 47 (2000) 85-118
25. Guigonis V., Dallocchio A., Baudouin V., et al. Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatric Nephrology (Berlin, Germany) 23 (2008) 1269-1279
26. Mizoguchi A., and Bhan A.K. A case for regulatory B cells. Journal of Immunology 176 (2006) 705-710
27. Joao C., Ogle B.M., Gay-Rabinstein C., Platt J.L., and Cascalho M. B cell-dependent TCR diversification. Journal of Immunology 172 (2004) 4709-4716
28. Khan A.Q., Sen G., Guo S., Witte O.N., and Snapper C.M. Induction of in vivo antipolysaccharide immunoglobulin responses to intact Streptococcus pneumoniae is more heavily dependent on Btk-mediated B-cell receptor signaling than antiprotein responses. Infection and Immunity 74 (2006) 1419-1424
29. Guven A.G., Akman S., Bahat E., et al. Rapid decline of anti-pneumococcal antibody levels in nephrotic children. Pediatric Nephrology (Berlin, Germany) 19 (2004) 61-65
30. Thomas R.K., Re D., Wolf J., and Diehl V. Part I: Hodgkin's lymphoma-molecular biology of Hodgkin and Reed-Sternberg cells. The Lancet Oncology 5 (2004) 11-18
31. Bargou R.C., Leng C., Krappmann D., et al. High-level nuclear NF-kappa B and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells. Blood 87 (1996) 4340-4347
32. Sahali D., Pawlak A., Le Gouvello S., et al. Transcriptional and post-transcriptional alterations of IkappaBalpha in active minimal-change nephrotic syndrome. Journal of the American Society of Nephrology 12 (2001) 1648-1658
33. Alzamora M.G., Schmidli M., Hess U., Cathomas R., and von Moos R. Minimal change glomerulonephritis in chronic lymphocytic leukemia: pathophysiological and therapeutic aspects. Onkologie 29 (2006) 153-156
34. Pacquement H., Sinnassamy P., Quintana E., Thomas C., Bensman A., and Zucker J.M. [Nephrotic syndrome and B leukemia]. Archives Francaises de Pediatrie 46 (1989) 741-742
35. D'Agati V., Sablay L.B., Knowles D.M., and Walter L. Angiotropic large cell lymphoma (intravascular malignant lymphomatosis) of the kidney: presentation as minimal change disease. Human Pathology 20 (1989) 263-268
36. Schofield K.P., Vites N., Geary C.G., Gokal R., and Mallick M.P. Nephrotic syndrome and hairy cell leukaemia. British Journal of Haematology 60 (1985) 389-390
37. Cho B.S., Yoon S.R., Jang J.Y., Pyun K.H., and Lee C.E. Up-regulation of interleukin-4 and CD23/FcepsilonRII in minimal change nephrotic syndrome. Pediatric Nephrology (Berlin, Germany) 13 (1999) 199-204
38. Kemper M.J., Meyer-Jark T., Lilova M., and Muller-Wiefel D.E. Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome. Clinical Nephrology 60 (2003) 242-247
39. Bonnefoy J.Y., Lecoanet-Henchoz S., Gauchat J.F., et al. Structure and functions of CD23. International Reviews of Immunology 16 (1997) 113-128
40. Meuleman N., Stamatopoulos B., Dejeneffe M., El Housni H., Lagneaux L., and Bron D. Doubling time of soluble CD23: a powerful prognostic factor for newly diagnosed and untreated stage A chronic lymphocytic leukemia patients. Leukemia 22 (2008) 1882-1890
41. Ali A.A., Wilson E., Moorhead J.F., et al. Minimal-change glomerular nephritis. Normal kidneys in an abnormal environment?. Transplantation 58 (1994) 849-852
42. Rea R., Smith C., Sandhu K., Kwan J., and Tomson C. Successful transplant of a kidney with focal segmental glomerulosclerosis. Nephrology Dialysis Transplantation 16 (2001) 416-417
43. Kemper M.J., Wolf G., and Muller-Wiefel D.E. Transmission of glomerular permeability factor from a mother to her child. The New England Journal of Medicine 344 (2001) 386-387
44. Lagrue G., Niaudet P., Guillot F., and Lang P. Pregnancy and glomerulonephritis. Lancet 2 (1989) 1037
45. Kemper M.J., Altrogge H., Ganschow R., and Muller-Wiefel D.E. Serum levels of immunoglobulins and IgG subclasses in steroid sensitive nephrotic syndrome. Pediatric Nephrology (Berlin, Germany) 17 (2002) 413-417
46. Giangiacomo J., Cleary T.G., Cole B.R., Hoffsten P., and Robson A.M. Serum immunoglobulins in the nephrotic syndrome. A possible cause of minimal-change nephrotic syndrome. The New England Journal of Medicine 293 (1975) 8-12
47. Lapillonne H., Leclerc A., Ulinski T., et al. Stem cell mobilization in idiopathic steroid-sensitive nephrotic syndrome. Pediatric Nephrology (Berlin, Germany) 23 (2008) 1251-1256
48. Habib R., Girardin E., Gagnadoux M.F., Hinglais N., Levy M., and Broyer M. Immunopathological findings in idiopathic nephrosis: clinical significance of glomerular "immune deposits". Pediatric Nephrology (Berlin, Germany) 2 (1988) 402-408
49. Le Berre F., Hamard C., Pena O., and Wojakowski A. Structural studies on single crystals of Chevrel phase selenides REMo6Se8 (RE = La, Ce, Pr, Nd, or Sm) at 298 K. Inorganic Chemistry 39 (2000) 1100-1105
50. Dantal J., Bigot E., Bogers W., et al. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. The New England Journal of Medicine 330 (1994) 7-14
51. Dantal J., Godfrin Y., Koll R., et al. Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome. Journal of the American Society of Nephrology 9 (1998) 1709-1715
52. Mallick N.P., Dosa S., Acheson E.J., et al. Detection, significance and treatment of paraprotein in patients presenting with 'idiopathic' proteinuria without myeloma. The Quarterly Journal of Medicine 47 (1978) 145-175
53. Hory B., Saunier F., Wolff R., Saint-Hillier Y., Coulon G., and Perol C. Waldenstrom macroglobulinemia and nephrotic syndrome with minimal change lesion. Nephron 45 (1987) 68-70
54. Solomon A. Bence Jones proteins and light chains of immunoglobulins. XV. Effect of corticosteroids on synthesis and excretion of Bence Jones protein. The Journal of Clinical Investigation 61 (1978) 97-108
55. Alexanian R., Haut A., Khan A.U., et al. Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens. Journal of the American Medical Association 208 (1969) 1680-1685
56. Carey W.P., Rico M.J., Nierodzik M., and Sidhu G. Systemic plasmacytosis with cutaneous manifestations in a white man: successful therapy with cyclophosphamide/prednisone. Journal of the American Academy of Dermatology 38 (1998) 629-631
57. Deen W.M., Brenner B.M., and Robertson C.R. Glomerular filtration. In: Brenner B. (Ed). The kidney vol. 1 (1976), Saunders, Philadelphia 251-271
58. Pavenstadt H., Kriz W., and Kretzler M. Cell biology of the glomerular podocyte. Physiological Reviews 83 (2003) 253-307
59. Verma R., Kovari I., Soofi A., Nihalani D., Patrie K., and Holzman L.B. Nephrin ectodomain engagement results in Src kinase activation, nephrin phosphorylation, Nck recruitment, and actin polymerization. The Journal of Clinical Investigation 116 (2006) 1346-1359
60. Sanz M.L., Prieto I., Garcia B.E., and Oehling A. Diagnostic reliability considerations of specific IgE determination. Journal of Investigational Allergology and Clinical Immunology 6 (1996) 152-161
61. A.D. Kraneveld, M. Kool, A.H. van Houwelingen, et al., Elicitation of allergic asthma by immunoglobulin free light chains, Proceedings of the National Academy of Sciences of the United States of America 102 (2005) 1578-1583.
62. Redegeld F.A., van der Heijden M.W., Kool M., et al. Immunoglobulin-free light chains elicit immediate hypersensitivity-like responses. Nature Medicine 8 (2002) 694-701
63. Thio M., Blokhuis B.R., Nijkamp F.P., and Redegeld F.A. Free immunoglobulin light chains: a novel target in the therapy of inflammatory diseases. Trends in Pharmacological Sciences 29 (2008) 170-174
64. Cheung W., Wei C.L., Seah C.C., Jordan S.C., and Yap H.K. Atopy, serum IgE, and interleukin-13 in steroid-responsive nephrotic syndrome. Pediatric Nephrology (Berlin, Germany) 19 (2004) 627-632
65. Lin C.Y., Lee B.H., Lin C.C., and Chen W.P. A study of the relationship between childhood nephrotic syndrome and allergic diseases. Chest 97 (1990) 1408-1411
66. Thiagarajan P., Dannenbring R., Matsuura K., Tramontano A., Gololobov G., and Paul S. Monoclonal antibody light chain with prothrombinase activity. Biochemistry 39 (2000) 6459-6465
67. Zwaginga J.J., Koomans H.A., Sixma J.J., and Rabelink T.J. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions. The Journal of Clinical Investigation 93 (1994) 204-211
68. Jokiranta T.S., Solomon A., Pangburn M.K., Zipfel P.F., and Meri S. Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H. Journal of Immunology 163 (1999) 4590-4596
69. Peled J.U., Kuang F.L., Iglesias-Ussel M.D., et al. The biochemistry of somatic hypermutation. Annual Review of Immunology 26 (2008) 481-511
70. Luetscher Jr. J.A., and Deming Q.B. Treatment of nephrosis with cortisone. The Journal of Clinical Investigation 29 (1950) 1576-1587